On a Mission to End Diabetes
Diabetes is the seventh-leading cause of death in the United States. The Diabetes Group at Sanford Research aims to fight this public health threat by researching type 1 and gestational diabetes.
We have a special interest in type 1 diabetes with The Sanford Project, an initiative to cure type 1 diabetes – the type that typically affects children.
We plan to end type 1 diabetes through discovery in three key areas:
- Autoimmunity: stopping the immune system’s attack on the body’s insulin-producing beta cells
- Prevention: identifying children at high risk and intervening before the onset of autoimmunity
- Regeneration: harnessing advancements in regenerative medicine to stimulate repair mechanisms and reboot insulin-producing beta cells
Our comprehensive strategy promises faster progress toward improving diabetes patients’ lives.
The Diabetes research group supports:
Primary Faculty
Secondary Faculty
Sanford Health News
-
background-image
Women-led cancer research at Sanford earns ACS funding
Dr. Pilar de la Puente also is named an American Cancer Society ResearcHERS Scholar
-
background-image
Early-phase cancer treatments available at Sanford Health
Sanford Health’s dynamic approach to cancer care offers access to clinical trials
Classes & Events
-
background-image
PROMISE Summer Programs
Mon 06/03/24 8:30 AM - Mon 06/03/24 3:00 PM
Sanford PROMISE Community Lab -
background-image
Eastern South Dakota Research Symposium
Wed 06/12/24 8:30 AM - Wed 06/12/24 4:30 PM
The Sanford Center, Dakota Room